# Diamante SRL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diamante

- Industry: Biotechnology
- Headquarters: Verona, Italy
- Website: www.diamante.tech
- Total disclosed funding: $0.7M
- Latest round: Seed (Jan 17, 2023)
- Investors on record: 2

## About

Based in Italy, and founded in 2016, Diamante (DIagnosis and therapy of Autoimmune Diseases by Nano-Technologie) is a biotech company focused on the use of plant viruses for producing auto-immune diagnoses and therapies for humans. In January 2023, Diamante SRL raised EUR 595,000 in seed funding led by investor Arieli Capital Fund, with participation from individual investors. As of January 2023, the company is being led by its CEO, Valentina Garonzi. 

The firm offers immunization therapies for diseases such as Rheumatoid Arthritis (RA) based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. The company also provides and develops tools and devices for autoimmune disease diagnosis using nanomaterials.

## Funding rounds

- Seed, Jan 17, 2023, $0.7M — Arieli Group, Angels4Women

## Investors

- Arieli Group (https://capitalatlas.ai/funds/arieli-group) — Seed
- Angels4Women (https://capitalatlas.ai/funds/angels4women) — Seed